ArchiMed acquires In Vitro Diagnostics specialist in cross-border carve-out
The acquisition marks the pan-European healthcare private equity specialist’s second cross-border corporate carve-out in less than three months. Similar deals are expected to follow.
ArchiMed take-private bid for Bomi Group concludes successfully
ArchiMed brings the take-private strategy to the mid-cap market with its acquisition. The pan-European healthcare private equity specialist expects to execute other take-private deals.
The pan-European private equity healthcare specialist’s approximately €70 million bid has the support of Bomi Group’s founding family and other shareholders controlling some 70 percent of the quoted firm.
Le projet, qui porte sur un traitement contre le paludisme dans les régions endémiques, est porté par Provepharm Life Solutions et son partenaire, le Walter Reed Army Institute of Research.
Soutenue par Archimed et Thétys pour relancer le bleu de méthylène et d’autres molécules à potentiel, la bipopharma acquiert le petit laboratoire de Seyne-sur-Seine, Lexpharm.
Partnership reinforces strategy of independent pharmaceutical group Provepharm Life Solutions and constitutes major step forward in its development